Our Pricing

Understanding Mounjaro Offers and Pricing in the UK

Published: 10 September 2026

Finding genuine mounjaro offers in the UK requires careful consideration of both price and pharmacy credentials. At Cured Pharmacy, we provide transparent upfront pricing from £124.99 with £20 off your first order using code Weightlossnew, ensuring you access licensed tirzepatide injections through a GPhC-registered service. All Mounjaro prescriptions require clinical assessment by our UK-registered prescribers to confirm suitability and safety.

Current Mounjaro Offers at Cured Pharmacy

Our mounjaro offers are designed to provide both value and clinical safety for patients seeking weight loss treatment. Cured Pharmacy offers Mounjaro from £124.99, with new patients eligible for £20 off their first order using the code Weightlossnew, bringing the effective starting price to £124.99[1]. This pricing structure includes a free online consultation with our UK-registered clinical team, completed in under three minutes, ensuring every prescription is issued only after thorough medical assessment.

Unlike promotional offers that may compromise on service quality, our mounjaro offers include comprehensive clinical support throughout your treatment journey. Each prescription is reviewed by our superintendent pharmacist Tarun Kumar (GPhC 2233073), and all medications are sourced exclusively from UK-licensed suppliers. The transparent pricing model means you see the exact cost before beginning your consultation, with no hidden fees or surprise charges at checkout.

How Mounjaro Offers Compare Across UK Pharmacies

When evaluating mounjaro offers, price is only one factor in determining genuine value. Cured Pharmacy's offer at £124.99 for first-time patients includes several elements that other services may charge separately: clinical consultation, prescriber review, discreet packaging, and ongoing customer support[2]. Our GPhC registration (9012511) ensures compliance with UK pharmaceutical regulations, providing assurance that every aspect of your treatment meets stringent safety standards.

The most competitive mounjaro offers balance affordability with clinical integrity. Some online services advertise lower headline prices but add consultation fees, delivery charges, or subscription commitments that inflate the total cost. At Cured Pharmacy, the price you see is the price you pay, with the added benefit of our lowest price guarantee across the UK market. This transparency helps patients make informed decisions without navigating complex pricing structures or conditional discounts.

What's Included in Our Mounjaro Offers

Every mounjaro offer at Cured Pharmacy includes a complete treatment package: free online consultation with a UK prescriber, clinical review by our superintendent pharmacist, dispensing of genuine UK-licensed Mounjaro (tirzepatide) KwikPen injections, and discreet next-day delivery. The £20 discount with code Weightlossnew applies automatically at checkout for first orders, reducing the starting price from £124.99 to £124.99. Subsequent prescriptions maintain competitive pricing without requiring subscription lock-ins or minimum order commitments.

Clinical Effectiveness Behind Mounjaro Offers

The value proposition of mounjaro offers extends beyond pricing to the clinical outcomes patients can expect. Tirzepatide, the active ingredient in Mounjaro, demonstrated average weight loss of 15-20% of body weight in the SURPASS clinical trial programme, significantly outperforming placebo and other weight management interventions[3]. These results, achieved over 72 weeks, represent substantial and sustained weight reduction when combined with dietary modifications and increased physical activity.

Understanding the clinical evidence helps contextualise mounjaro offers within the broader weight loss treatment landscape. In the SURMOUNT-1 trial, participants receiving the 15mg tirzepatide dose lost an average of 20.9% of their initial body weight, compared to 3.1% in the placebo group[4]. This efficacy profile, combined with Mounjaro's dual GIP/GLP-1 receptor agonist mechanism, explains why clinicians increasingly recommend tirzepatide for patients with obesity or weight-related health conditions, subject to prescriber approval and medical suitability.

Mounjaro Dosing and Treatment Duration

Mounjaro offers typically cover a four-week supply at a specified dose, with treatment beginning at 2.5mg weekly for the first month. The dose escalates gradually—to 5mg, then 7.5mg, 10mg, 12.5mg, and finally 15mg—based on individual response and tolerability[5]. This titration schedule, reflected in our pricing structure, minimises gastrointestinal side effects whilst optimising weight loss outcomes. Most patients remain on treatment for 12-18 months to achieve and consolidate their weight loss goals, though duration varies based on clinical response and prescriber guidance.

Eligibility Criteria for Mounjaro Offers

Accessing mounjaro offers requires meeting specific clinical criteria established by the MHRA and prescribing guidelines. Mounjaro is licensed for adults with a BMI of 30 kg/m² or above, or 27 kg/m² or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidaemia[6]. Our online consultation assesses these criteria alongside contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, and pregnancy or breastfeeding.

The clinical assessment process ensures mounjaro offers reach only those patients for whom tirzepatide represents an appropriate and safe intervention. During your consultation, our prescribers review your medical history, current medications, and weight loss goals to determine suitability. This thorough evaluation protects patient safety whilst ensuring compliance with UK prescribing regulations. Patients who do not meet Mounjaro criteria may be offered alternative weight loss treatments such as Wegovy, Saxenda, or Orlistat, depending on their clinical profile.

Maximising Value from Mounjaro Offers

To optimise outcomes from mounjaro offers, patients should integrate tirzepatide treatment with lifestyle modifications including a reduced-calorie diet and increased physical activity. Clinical trials demonstrate that the greatest weight loss occurs when Mounjaro is combined with behavioural interventions, creating a synergistic effect that enhances both the magnitude and sustainability of results[7]. Our clinical team provides guidance on nutrition and exercise strategies tailored to your individual circumstances, maximising the value of your investment in treatment.

Long-term success with mounjaro offers also depends on consistent medication adherence and regular follow-up. Missing doses or discontinuing treatment prematurely can compromise weight loss outcomes and increase the likelihood of weight regain. At Cured Pharmacy, we support ongoing treatment through convenient repeat prescription services, ensuring you maintain therapeutic continuity without gaps in medication supply. Our patient support team is available via phone ((+44) 116 4646009) to address questions or concerns throughout your treatment journey.

Managing Side Effects During Treatment

The most common side effects associated with Mounjaro include nausea, diarrhoea, vomiting, constipation, and abdominal discomfort, typically most pronounced during dose escalation phases[8]. These gastrointestinal symptoms usually diminish within several weeks as the body adapts to treatment. Patients can minimise discomfort by eating smaller, more frequent meals, avoiding high-fat foods, and staying well-hydrated. If side effects persist or become severe, consult your prescriber, who may adjust your dose or recommend alternative management strategies.

How to Claim Mounjaro Offers at Cured Pharmacy

Claiming mounjaro offers at Cured Pharmacy follows a straightforward process designed for convenience and clinical safety. Begin by completing our free online consultation, which takes under three minutes and covers your medical history, current health status, and weight loss objectives. Once submitted, a UK-registered prescriber reviews your assessment, typically within 24 hours. If Mounjaro is deemed appropriate, your prescription is issued and forwarded to our pharmacy team for dispensing.

To apply the £20 discount, enter the code Weightlossnew at checkout, reducing your first order from £124.99 to £124.99. Payment is processed securely, and your medication is dispatched in 100% discreet packaging with next-day delivery to your preferred address. All mounjaro offers at Cured Pharmacy include ongoing access to our clinical support team, ensuring you receive expert guidance throughout your treatment. Repeat prescriptions can be ordered through your online account, maintaining continuity of care without repeated consultations, subject to prescriber approval.

Scientific References

1. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/ [accessed 10 September 2026]
2. General Pharmaceutical Council. (2024). Standards for registered pharmacies. Retrieved from https://www.pharmacyregulation.org/ [accessed 10 September 2026]
3. Rosenstock, J., Wysham, C., Frías, J. P., Kaneko, S., Lee, C. J., Fernández Landó, L., ... & Huh, R. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143-155. [accessed 10 September 2026]
4. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Garvey, W. T. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 10 September 2026]
5. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating type 2 diabetes. NICE technology appraisal guidance [TA924]. [accessed 10 September 2026]
6. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro (tirzepatide): authorised indication and prescribing information. Drug Safety Update, 16(9). [accessed 10 September 2026]
7. Wadden, T. A., Bailey, T. S., Billings, L. K., Davies, M., Frias, J. P., Koroleva, A., ... & Garvey, W. T. (2021). Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity. JAMA, 325(14), 1403-1413. [accessed 10 September 2026]
8. Dahl, D., Onishi, Y., Norwood, P., Huh, R., Bray, R., Patel, H., & Rodríguez, Á. (2022). Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: the SURPASS-5 randomized clinical trial. JAMA, 327(6), 534-545. [accessed 10 September 2026]
9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 10 September 2026.
10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 10 September 2026.
11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 10 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.